|
(9) Therapeutic strategies to mitigate toxicities of platinum-based therapeutics
|
5R01CA215802-02
|
$511,546
|
SPARREBOOM, ALEXANDER
|
OHIO STATE UNIVERSITY
|
|
(PQ 12) Targeting SMPDL3b to Prevent Radiation-Induced Nephrotoxicity
|
1R01CA227493-01
|
$427,990
|
MARPLES, BRIAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis
|
5R21CA216304-02
|
$195,750
|
NEWMEYER, DONALD
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
|
5R01CA205965-02
|
$640,839
|
CURIEL, TYLER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-03
|
$703,249
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
5R01CA216054-02
|
$324,411
|
HAYDEN GEPHART, MELANIE
|
STANFORD UNIVERSITY
|
|
(PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer
|
5R01CA206483-02
|
$570,958
|
EMU, BRINDA
|
YALE UNIVERSITY
|
|
(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy
|
1R01CA219871-01A1
|
$451,326
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
|
5R21CA206309-02
|
$182,192
|
HARRIS, REUBEN
|
UNIVERSITY OF MINNESOTA
|
|
(PQ3) A functional genomic approach to identification and interpretation of germline-tumor genetic interactions
|
1R01CA227237-01
|
$686,519
|
GUSEV, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-03
|
$334,552
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ4A) Metabolic Plasticity of Pre-Malignant Cells During Tumor Progression
|
5R01CA194461-04
|
$334,291
|
PARK, KWON-SIK
|
UNIVERSITY OF VIRGINIA
|
|
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
|
5R01CA216242-02
|
$319,238
|
MACLEOD, KAY
|
UNIVERSITY OF CHICAGO
|
|
(PQ5) Effect of HIV infection on viral and host gene expression and antitumor immunity in Kaposi Sarcoma in Africa
|
5R01CA217138-02
|
$723,817
|
WARREN, EDUS
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQ5) Informing anal neoplasia differences/similarities in HIV-serodiscordant individuals
|
5R21CA216830-02
|
$192,500
|
SHIRAMIZU, BRUCE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
|
5R01CA206012-02
|
$402,548
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
|
5R01CA206012-03
|
$403,884
|
FACCIABENE, ANDREA
|
UNIVERSITY OF PENNSYLVANIA
|
|
(PQ5) Role of Mitochondrial Division in Cancer Biology
|
5R01CA206005-02
|
$351,209
|
CHIPUK, JERRY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQ5) Role of Mitochondrial Division in Cancer Biology
|
5R01CA206005-03
|
$351,209
|
CHIPUK, JERRY
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
|
5R01CA185293-04
|
$329,104
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
(PQA5) 'Dose and Mechanisms of Exercise in Breast Cancer Prevention'
|
5R01CA179992-04
|
$909,181
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
5R01CA185062-04
|
$312,304
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
|
5R01CA185020-04
|
$325,181
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-03
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQB4) Stochastic Profiling of Functional Single-Cell States Within Solid Tumors
|
5R01CA194470-04
|
$446,627
|
JANES, KEVIN
|
UNIVERSITY OF VIRGINIA
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
5R01CA185486-04
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
5R01CA185137-04
|
$882,372
|
CHAREST, ALAIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-03
|
$553,740
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQC2) Localization as a determinant of cancer dormancy
|
5R01CA194596-04
|
$525,066
|
LIN, CHARLES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQC2)Nanoscale changes in 3D nuclear architecture during breast tumorigenesis
|
5R01CA185363-04
|
$318,250
|
LIU, YANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQC6) Molecular Determinants of Quiescent Cancer Cells
|
5R01CA185086-04
|
$423,327
|
VASUDEVAN, SHOBHA
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
|
5R01CA184320-04
|
$738,276
|
SARKARIA, JANN
|
MAYO CLINIC ROCHESTER
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
01/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048377-24
|
$39,000
|
GADDE, KISHORE
|
LSU PENNINGTON BIOMEDICAL RESEARCH CTR
|
|
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048381-24
|
$68,181
|
EHRMANN, DAVID
|
UNIVERSITY OF CHICAGO
|
|
03/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048468-24
|
$68,181
|
Furlong, Kevin
|
THOMAS JEFFERSON UNIVERSITY
|
|
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048434-24
|
$68,181
|
Goldberg, Ronald
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
05/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Proj
|
U01DK048514-24
|
$68,181
|
HAZUDA, HELEN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
06/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048375-24
|
$68,181
|
Dabelea, Dana
|
UNIVERSITY OF COLORADO DENVER
|
|
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 Research Project
|
U01DK048437-24
|
$42,300
|
Horton, Edward
|
JOSLIN DIABETES CENTER
|
|
07/22 Diabetes Prevention Program Outcomes Study (DPPOS)Phase 3 - Research Project
|
5U01DK048437-25
|
$42,300
|
MUNSHI, MEDHA
|
JOSLIN DIABETES CENTER
|
|
08/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048413-24
|
$68,181
|
Kahn, Steven
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
|
09/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048411-24
|
$37,181
|
DAGOGO-JACK, SAMUEL
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
1 BASE PERIOD: HDRP MEETING AND WORK GROUP SUPPORT $27,711.89
|
261201400011I
|
$1,353,862
|
UNKNOWN, UNKNOWN
|
SCIENTIFIC CONSULTING GRO
|
|
10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Project
|
U01DK048380-24
|
$68,181
|
Molitch, Mark
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048397-24
|
$68,181
|
NATHAN, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
13/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048404-24
|
$68,181
|
PI-SUNYER, XAVIER
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
14/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048406-24
|
$68,181
|
MATHER, KIEREN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
15/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048387-24
|
$68,181
|
Magee, Michelle
|
MEDSTAR HEALTH RESEARCH INSTITUTE
|
|
16/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 Research Projec
|
U01DK048443-24
|
$68,181
|
WATSON, KAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|